Mitochondrial targeting as a novel therapy for stroke
Open Access
- 1 January 2018
- journal article
- review article
- Published by Medknow in Brain Circulation
- Vol. 4 (3) , 84-94
Abstract
Stroke is a main cause of mortality and morbidity worldwide. Despite the increasing development of innovative treatments for stroke, most are unsuccessful in clinical trials. In recent years, an encouraging strategy for stroke therapy has been identified in stem cells transplantation. In particular, grafting cells and their secretion products are leading with functional recovery in stroke patients by promoting the growth and function of the neurovascular unit - a communication framework between neurons, their supply microvessels along with glial cells - underlying stroke pathology and recovery. Mitochondrial dysfunction has been recently recognized as a hallmark in ischemia/reperfusion neural damage. Emerging evidence of mitochondria transfer from stem cells to ischemic-injured cells points to transfer of healthy mitochondria as a viable novel therapeutic strategy for ischemic diseases. Hence, a more in-depth understanding of the cellular and molecular mechanisms involved in mitochondrial impairment may lead to new tools for stroke treatment. In this review, we focus on the current evidence of mitochondrial dysfunction in stroke, investigating favorable approaches of healthy mitochondria transfer in ischemic neurons, and exploring the potential of mitochondria-based cellular therapy for clinical applications. This paper is a review article. Referred literature in this paper has been listed in the references section. The data sets supporting the conclusions of this article are available online by searching various databases, including PubMed.Keywords
This publication has 180 references indexed in Scilit:
- Mitochondrial Ca2+ and apoptosisCell Calcium, 2012
- Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activationCell Death & Disease, 2011
- Human Mesenchymal Stem Cells Reprogram Adult Cardiomyocytes Toward a Progenitor-Like State Through Partial Cell Fusion and Mitochondria TransferStem Cells, 2011
- Protein deacetylation by SIRT1: An emerging key post-translational modification in metabolic regulationPharmacological Research, 2010
- Biochemical diagnosis of mitochondrial disordersJournal of Inherited Metabolic Disease, 2010
- Caloric restriction, SIRT1 and longevityTrends in Endocrinology & Metabolism, 2009
- Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1–uncoupling protein 2 pathwayNeuroscience, 2009
- Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cellsAngiogenesis, 2007
- Metabolic adaptations through the PGC‐1α and SIRT1 pathwaysFEBS Letters, 2007
- Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction SignalCell, 2003